Preliminary studies point out conolidine may perhaps inhibit unique ion channels, reducing neuronal excitability and limiting soreness signals. This mechanism is particularly suitable in neuropathic agony, in which abnormal signaling brings about persistent distress. Furthermore, conolidine seems to influence G protein-coupled receptor (GPCR) pathw